EVOSEP and ReSyn Biosciences partner to integrate their technologies into new clinical proteomics solutions

The ability to process large and clinically relevant cohorts in a robust and high-throughput manner is important to unlocking the full potential of proteomics for precision medicine. The latest generation of mass spectrometers allows for highly sensitive and high throughput proteome profiling, shifting the emphasis to robust sample preparation and separation. The aim being to provide seamless sample to mass spectrometer solutions that are both sensitive and simple to implement, with the throughput required to meet the needs of clinical applications in proteomics

ReSyn Biosciences and Evosep have recently demonstrated several joint solutions that integrate automated sample purification with liquid chromatography coupled mass spectrometry. They are currently expanding the collaboration to provide further innovative solutions by announcing that Dr. Stoyan Stoychev, who leads the proteomics applications development at ReSyn Biosciences, will be co-joining the applications development team at Evosep, with the aim of accelerating developments in this field.

 “We are excited about this joint appointment and believe that it will lead to better integrations of our technologies in solutions that meet the needs of the emerging field of clinical proteomics”.

Dr. Justin Jordaan, CEO & CSO, ReSyn Biosciences.

ReSyn’s expertise with bead-based workflows fits perfectly with Evosep’s ambition of standardizing and automating end-to-end proteomic workflows. We share the goal of developing standardized and modular end-to-end workflows that consists of individual functional units that can be added or removed as needed to collectively define different end-to-end workflows. Stoyan has extensive experience in this space and through this shared position, he will be a central part of developing and supporting solutions that drive proteomics towards clinical use.”

Dr. Nicolai Bache, Head of Applications, Evosep.